[1] S. L. Jacques, B.W. Pogue, “Tutorial on diffuse light transport,” J. Biomed. Opt. 13, 041302 (2008).

[2] D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: A systematic review,” Breast Cancer Res. Treat. 108, 9–22 (2008).

[3] A. Hagen, D. Grosenick, R. Macdonald, H. Rinneberg, S. Burock, P. Warnick, A. Poellinger, P. M. Schlag, “Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions,” Opt. Express 17, 17016–17033 (2009).

[4] S. van de Ven, A. Wiethoff, T. Nielsen, B. Brendel, M. van der Voort, R. Nachabe, M. Van der Mark, M. Van Beek, L. Bakker, L. Fels, S. Elias, P. Luijten, W. Mali, “A novel fluorescent imaging agent for diffuse optical tomography of the breast: First clinical experience in patients,” Mol. Imaging Biol. 12, 343–348 (2010).

[5] Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, D. A. Boas, “Combined optical imaging and mammography of the healthy breast: Optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28, 30–42 (2009).

[6] C. M. Carpenter, S. Srinivasan, B. W. Pogue, K. D. Paulsen, “Methodology development for threedimensional MR-guided near infrared spectroscopy of breast tumors,” Opt. Express 16, 17903–17914 (2008).

[7] Q. Zhu, P. U. Hegde, A. Ricci Jr, M. Kane, E. B. Cronin, Y. Ardeshirpour, C. Xu, A. Aguirre, S. H. Kurtzman, P. J. Deckers, S. H. Tannenbaum, “Early-stage invasive breast cancers: Potential role of optical tomography with US localization in assisting diagnosis,” Radiology 256, 367–378 (2010).

[8] A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. USA 104, 4014–4019 (2007).

[9] S. Kukreti, A. E. Cerussi, W. Tanamai, D. Hsiang, B. J. Tromberg, E. Gratton, “Characterization of metabolic differences between benign and malignant tumors: High-spectral-resolution diffuse optical spectroscopy,” Radiology 254, 277–284 (2010).

[10] J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37, 3715–3724 (2010).

[11] P. Taroni, A. Pifferi, E. Salvagnini, L. Spinelli, A. Torricelli, R. Cubeddu, “Seven-wavelength timeresolved optical mammography extending beyond 1000 nm for breast collagen quantification,” Opt. Express 17, 15932–15946 (2009).

[12] R. Choe, S. D. Konecky, A. Corlu, K. Lee, T. Durduran, D. R. Busch, S. Pathak, B. J. Czerniecki, J. Tchou, D. L. Fraker, A. Demichele, B. Chance, S. R. Arridge, M. Schweiger, J. P. Culver, M. D. Schnall, M. E. Putt, M. A. Rosen, A. G. Yodh, “Differentiation of benign and malignant breast tumors by in vivo three-dimensional parallel-plate diffuse optical tomography,” J. Biomed. Opt. 14, 024020 (2009).

[13] D. R. Busch,W. Guo, R. Choe, T. Durduran, M. D. Feldman, C. Mies, M. A. Rosen, M. D. Schnall, B. J. Czerniecki, J. Tchou, A. DeMichele, M. E. Putt, A. G. Yodh, “Computer aided automatic detection of malignant lesions in diffuse optical mammography,” Med. Phys. 37, 1840–1849 (2010).

[14] M. L. Flexman, Y. Li, A. M. Bur, C. J. Fong, J. M. Masciotti, R. Al Abdi, R. L. Barbour, A. H. Hielscher, “The design and characterization of a digital optical breast cancer imaging system,” Conf. Proc. IEEE Eng. Med. Biol. Soc. 2008, 3735–3738 (2008).

[15] G. Boverman, Q. Fang, S. A. Carp, E. L. Miller, D. H. Brooks, J. Selb, R. H. Moore, D. B. Kopans, D. A. Boas, “Spatio-temporal imaging of the hemoglobin in the compressed breast with diffuse optical tomography,” Phys. Med. Biol. 52, 3619–3641 (2007).

[16] N. Liu, A. Sassaroli, S. Fantini, “Paired-wavelength spectral approach to measuring the relative concentrations of two localized chromophores in turbid media: An experimental study,” J. Biomed. Opt. 12, 051602 (2007).

[17] V. E. Pera, E. L. Heffer, H. Siebold, O. Schutz, S. Heywang-Kobrunner, L. Gotz, A. Heinig, S. Fantini, “Spatial second-derivative image processing: An application to optical mammography to enhance the detection of breast tumors,” J. Biomed. Opt. 8, 517–524 (2003).

[18] Y. Yu, N. Liu, A. Sassaroli, S. Fantini, “Nearinfrared spectral imaging of the female breast for quantitative oximetry in optical mammography,” Appl. Opt. 48, D225–35 (2009).

[19] S. Fantini, M. A. Franceschini, G. Gaida, E. Gratton, H. Jess, W. W. Mantulin, K. T. Moesta, P. M. Schlag, M. Kaschke, “Frequency-domain optical mammography: Edge effect corrections,” Med. Phys. 23, 149–157 (1996).

[20] G. M. Hale and M. R. Querry, “Optical constants of water in the 200-nm to 200-μm wavelength region,” Appl. Opt. 12, 555–563 (1973).

[21] R. L. van Veen, H. J. Sterenborg, A. Pifferi, A. Torricelli, E. Chikoidze, R. Cubeddu, “Determination of visible near-IR absorption coefficients of mammalian fat using time- and spatially resolved diffuse reflectance and transmission spectroscopy,” J. Biomed. Opt. 10, 054004 (2005).

[22] D. Hsiang, N. Shah, H. Yu, M. Y. Su, A. Cerussi, J. Butler, C. Baick, R. Mehta, O. Nalcioglu, B. Tromberg, “Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer,” Technol. Cancer. Res. Treat. 4, 549–558 (2005).

[23] Q. Zhu, S. Tannenbaum, P. Hegde, M. Kane, C. Xu, S. Kurtzman, “Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization,” Neoplasia 10, 1028–1040 (2008).